633 related articles for article (PubMed ID: 32623632)
1. Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study).
Sarin SK; Choudhury A; Lau GK; Zheng MH; Ji D; Abd-Elsalam S; Hwang J; Qi X; Cua IH; Suh JI; Park JG; Putcharoen O; Kaewdech A; Piratvisuth T; Treeprasertsuk S; Park S; Wejnaruemarn S; Payawal DA; Baatarkhuu O; Ahn SH; Yeo CD; Alonzo UR; Chinbayar T; Loho IM; Yokosuka O; Jafri W; Tan S; Soo LI; Tanwandee T; Gani R; Anand L; Esmail ES; Khalaf M; Alam S; Lin CY; Chuang WL; Soin AS; Garg HK; Kalista K; Batsukh B; Purnomo HD; Dara VP; Rathi P; Al Mahtab M; Shukla A; Sharma MK; Omata M;
Hepatol Int; 2020 Sep; 14(5):690-700. PubMed ID: 32623632
[TBL] [Abstract][Full Text] [Related]
2. Effect of COVID-19 on patients with compensated chronic liver diseases.
Ji D; Zhang D; Yang T; Mu J; Zhao P; Xu J; Li C; Cheng G; Wang Y; Chen Z; Qin E; Lau G
Hepatol Int; 2020 Sep; 14(5):701-710. PubMed ID: 32734407
[TBL] [Abstract][Full Text] [Related]
3. Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study.
Marjot T; Moon AM; Cook JA; Abd-Elsalam S; Aloman C; Armstrong MJ; Pose E; Brenner EJ; Cargill T; Catana MA; Dhanasekaran R; Eshraghian A; García-Juárez I; Gill US; Jones PD; Kennedy J; Marshall A; Matthews C; Mells G; Mercer C; Perumalswami PV; Avitabile E; Qi X; Su F; Ufere NN; Wong YJ; Zheng MH; Barnes E; Barritt AS; Webb GJ
J Hepatol; 2021 Mar; 74(3):567-577. PubMed ID: 33035628
[TBL] [Abstract][Full Text] [Related]
4. Poor outcomes in patients with cirrhosis and Corona Virus Disease-19.
Shalimar ; Elhence A; Vaishnav M; Kumar R; Pathak P; Soni KD; Aggarwal R; Soneja M; Jorwal P; Kumar A; Khanna P; Singh AK; Biswas A; Nischal N; Dar L; Choudhary A; Rangarajan K; Mohan A; Acharya P; Nayak B; Gunjan D; Saraya A; Mahapatra S; Makharia G; Trikha A; Garg P
Indian J Gastroenterol; 2020 Jun; 39(3):285-291. PubMed ID: 32803716
[TBL] [Abstract][Full Text] [Related]
5. High rates of 30-day mortality in patients with cirrhosis and COVID-19.
Iavarone M; D'Ambrosio R; Soria A; Triolo M; Pugliese N; Del Poggio P; Perricone G; Massironi S; Spinetti A; Buscarini E; Viganò M; Carriero C; Fagiuoli S; Aghemo A; Belli LS; Lucà M; Pedaci M; Rimondi A; Rumi MG; Invernizzi P; Bonfanti P; Lampertico P
J Hepatol; 2020 Nov; 73(5):1063-1071. PubMed ID: 32526252
[TBL] [Abstract][Full Text] [Related]
6. Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis.
Kumar-M P; Mishra S; Jha DK; Shukla J; Choudhury A; Mohindra R; Mandavdhare HS; Dutta U; Sharma V
Hepatol Int; 2020 Sep; 14(5):711-722. PubMed ID: 32623633
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of chronic liver disease with coronavirus disease 2019 (COVID-19): a cohort study in Wuhan, China.
Li C; Chen Q; Wang J; Lin H; Lin Y; Lin J; Peng F; Chen J; Yang Z
Aging (Albany NY); 2020 Aug; 12(16):15938-15945. PubMed ID: 32855361
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of chronic liver disease in patients with COVID-19 and their clinical outcomes: a systematic review and meta-analysis.
Kovalic AJ; Satapathy SK; Thuluvath PJ
Hepatol Int; 2020 Sep; 14(5):612-620. PubMed ID: 32725453
[TBL] [Abstract][Full Text] [Related]
9. Acute on chronic liver failure from novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Qiu H; Wander P; Bernstein D; Satapathy SK
Liver Int; 2020 Jul; 40(7):1590-1593. PubMed ID: 32369658
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes of coronavirus disease 2019 in patients with pre-existing liver diseases: A multicenter study in South Korea.
Lee YR; Kang MK; Song JE; Kim HJ; Kweon YO; Tak WY; Jang SY; Park JG; Lee C; Hwang JS; Jang BK; Suh JI; Chung WJ; Kim BS; Park SY
Clin Mol Hepatol; 2020 Oct; 26(4):562-576. PubMed ID: 33053932
[TBL] [Abstract][Full Text] [Related]
11. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
Webb GJ; Marjot T; Cook JA; Aloman C; Armstrong MJ; Brenner EJ; Catana MA; Cargill T; Dhanasekaran R; García-Juárez I; Hagström H; Kennedy JM; Marshall A; Masson S; Mercer CJ; Perumalswami PV; Ruiz I; Thaker S; Ufere NN; Barnes E; Barritt AS; Moon AM
Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):1008-1016. PubMed ID: 32866433
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of SARS-CoV-2 Infection in Patients With Chronic Liver Disease and Cirrhosis: A National COVID Cohort Collaborative Study.
Ge J; Pletcher MJ; Lai JC;
Gastroenterology; 2021 Nov; 161(5):1487-1501.e5. PubMed ID: 34284037
[TBL] [Abstract][Full Text] [Related]
13. COVID-19: Abnormal liver function tests.
Cai Q; Huang D; Yu H; Zhu Z; Xia Z; Su Y; Li Z; Zhou G; Gou J; Qu J; Sun Y; Liu Y; He Q; Chen J; Liu L; Xu L
J Hepatol; 2020 Sep; 73(3):566-574. PubMed ID: 32298767
[TBL] [Abstract][Full Text] [Related]
14. Clinical course of COVID-19 in patients with pre-existing decompensated cirrhosis: initial report from China.
Qi X; Wang J; Li X; Wang Z; Liu Y; Yang H; Li X; Shi J; Xiang H; Liu T; Kawada N; Maruyama H; Jiang Z; Wang F; Takehara T; Rockey DC; Sarin SK;
Hepatol Int; 2020 Jul; 14(4):478-482. PubMed ID: 32440857
[TBL] [Abstract][Full Text] [Related]
15. Impact of renal function on admission in COVID-19 patients: an analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID 19) Registry.
Uribarri A; Núñez-Gil IJ; Aparisi A; Becerra-Muñoz VM; Feltes G; Trabattoni D; Fernández-Rozas I; Viana-Llamas MC; Pepe M; Cerrato E; Capel-Astrua T; Romero R; Castro-Mejía AF; El-Battrawy I; López-País J; D'Ascenzo F; Fabregat-Andres O; Bardají A; Raposeiras-Roubin S; Marín F; Fernández-Ortiz A; Macaya C; Estrada V;
J Nephrol; 2020 Aug; 33(4):737-745. PubMed ID: 32602006
[TBL] [Abstract][Full Text] [Related]
16. Review article: COVID-19 and liver disease-what we know on 1st May 2020.
Garrido I; Liberal R; Macedo G
Aliment Pharmacol Ther; 2020 Jul; 52(2):267-275. PubMed ID: 32402090
[TBL] [Abstract][Full Text] [Related]
17. Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with chronic liver disease.
Hartl L; Haslinger K; Angerer M; Semmler G; Schneeweiss-Gleixner M; Jachs M; Simbrunner B; Bauer DJM; Eigenbauer E; Strassl R; Breuer M; Kimberger O; Laxar D; Lampichler K; Halilbasic E; Stättermayer AF; Ba-Ssalamah A; Mandorfer M; Scheiner B; Reiberger T; Trauner M
Hepatology; 2022 Dec; 76(6):1563-1575. PubMed ID: 35596929
[TBL] [Abstract][Full Text] [Related]
18. Clinical practice guidance for hepatology and liver transplant providers during the COVID-19 pandemic: APASL expert panel consensus recommendations.
; Lau G; Sharma M
Hepatol Int; 2020 Jul; 14(4):415-428. PubMed ID: 32447721
[TBL] [Abstract][Full Text] [Related]
19. Mortality Trends in Chronic Liver Disease and Cirrhosis in the United States, Before and During COVID-19 Pandemic.
Kim D; Bonham CA; Konyn P; Cholankeril G; Ahmed A
Clin Gastroenterol Hepatol; 2021 Dec; 19(12):2664-2666.e2. PubMed ID: 34256143
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 - more than respiratory disease: a gastroenterologist's perspective.
Konturek PC; Harsch IA; Neurath MF; Zopf Y
J Physiol Pharmacol; 2020 Apr; 71(2):. PubMed ID: 32633236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
